LTC Medical Practitioners and Pharmacists Conference

West Des Moines, IA US
July 21, 2017 to July 22, 2017

Click here to register. 

For assistance completing the online registration process, call 800.422.3106. All attendees must register and pay applicable fees. Walk-in registrations are accepted only if space permits. Pre-registration is strongly recommended.


This one-of-a-kind educational conference is for nursing facility administrators, nurses, medical directors, nurse practitioners, physician assistants, and pharmacists. The education will focus on bringing medical professionals and facility leadership together to discuss ways to improve the quality of care for nursing facility residents. Today’s rapidly changing healthcare environment includes new payment methodology tied to quality performance metrics and increased regulatory requirements to participate in federally funded health care programs.  These changes require all members of the professional interdisciplinary team to be knowledgeable and engaged to facilitate the successful realignment of post-acute and long term care delivery systems to meet these pressing needs. 


Speaker Bios

Friday, July 21

12:30 pm


1 pm

The New Requirements of Participation: What it Means for Medical Directors, Pharmacist and Other Practitioners

David R. Gifford, MD, MPH
Senior Vice President of Quality and Regulatory Affairs, American Health Care Association

In October 2016 CMS released the most comprehensive overhaul of the nursing facility Requirements of Participation since the implementation of the OBRA rules in 1987.  The new rules focus heavily on person-centered care approaches, the reduction of unnecessary drugs and the reduction of preventable hospitalizations.  The new requirements include a comprehensive facility assessment, much increased infection control requirements which include a formal antibiotic stewardship program, and the implementation of a formal QAPI process that includes the entire disciplinary team.  This session will help participants understand the scope and detail of the requirements and how the participants will need to engage in their provider roles with nursing facilities as implementation of the rules advances through Phases I, II and III.

  • Understand the changes in the federal rules which impact medical directors, consultant pharmacists, and other medical practitioners providing care in skilled nursing and nursing facilities.
  • Understand the role of the medical director, consultant pharmacist and resident specific medical providers in the development and implementation of the person-centered care plan.
  • Understand the role of the medical director and the consultant pharmacist in the implementation of QAPI in nursing facilities.
  • Understand the role of the medical director and consultant pharmacist in the expanded infection control program to be required in all facilities.
2:30 pmBreak
2:45 pmPanel Discussion: Current State and Federal Issues for Practitioners
  • Paul Mulhausen MD, MHS
    Chief Medical Officer, Telligen
  • Samuel E. Stanton, MD
    Practicing Family Practitioner, Hampton, IA
  • Cindy Baddeloo, PhD, MPA, RN
    Senior Vice President and Chief Operating Officer, Iowa Health Care Association
  • Mary Jane Carothers, RN, BA, LNHA, ALMC
    Vice President of Quality Improvement and Clinical Services, Iowa Health Care Association

Decisions made by the Iowa 2017 General Assembly and U.S. Congress have a direct impact on day-to-day operations in both your practice and patient care. Our panel members will share state and federal updates and insights on issues impacting PA/LTC practices in Iowa’s nursing and rehab centers. Attendees will also learn about resources the QIO/QIN and AMDA/PALTC have developed to help practitioners successfully adapt to regulatory changes and practices to be successful in the changing healthcare delivery and payment reform landscape.

  • Describe approaches for collaboration with your QIOs/QINs to be successful in the changing healthcare delivery and payment reform landscape.
  • Identify the impact of the recent state and proposed federal legislation on nursing and rehab centers and other long term services and supports.
  • Gain an understanding of Iowa’s performance in quality metrics and benchmarking, as well as, upcoming changes in metrics with value based purchasing.
  • Identify the resources available through the Society for Post-Acute and Long-Term Care Medicine.
4:15 pmAdjourn


Saturday, July 21

7:30 am

Breakfast and Networking

8:30 am

Medication-Related Changes and Antimicrobial Stewardship Guidance in MegaRules

Allen Bell, RPh, CGP, FASCP
Director of Clinical Services, Omnicare

Antibiotic stewardship will be a new concept to licensed nurses who have been working exclusively in long term care.  Nursing facility staff members will be looking to medical providers, medical directors and consultant pharmacists to provide information and guidance to draft programs and implement procedures to ensure that antibiotics and other drugs are used effectively and not unnecessarily among the elderly population they serve.  This session will help prepare participants to help nursing facilities implement programs that effectively reduce the use of unnecessary drugs.

  • Understand the new federal regulations relating to the use of antibiotics and other potentially unnecessary drugs.
  • Have increased role competency while serving as a medical director, consultant pharmacist or other medical providers in relation to the new rules.
  • Have increased knowledge of methods for implementing an effective antibiotic stewardship program.
  • Have increased knowledge of best practices for identifying and eliminating unnecessary drugs in nursing home populations.
10 amBreak

10:15 am

Opioid Use in Long Term Care

  • Jeff Reist, PharmD
    Clinical Associate Professor and Director of the Pharmacy Practice Laboratory, University of Iowa College of Pharmacy
  • Katy Brown, PharmD
    Clinical Pharmacy Specialist and the Medication Safety Task Coordinator, Telligen Quality Innovation Network-Quality Improvement Organization

This presentation will cover the use of opioids in the treatment of persistent non-cancer pain in the older adult with emphasis on consideration for residents of nursing facilities.  The evidence of the use of opioids will be examined as well as strategies to enhance patient safety when opioid therapy is indicated or required.

  • Explain the evidence for the use of opioids in the treatment of persistent pain in older adults
  • List specific risks of chronic opioid therapy in older adults
  • Calculate a patient-specific risk score for the use of opioid therapy
  • Manage opioid therapy in an older adult residing in a long-term care facility in adherence with federal nursing facility regulations and standards of care.

11:45 am


12:15 pm

Early Detection and Treatment of Sepsis

  • Christopher Hill, DO
    Board Certified Emergency Physician, Allen Hospital, Waterloo, IA
  • Geoffrey C. Wall, PhD
    Professor, Department of Clinical Sciences, College of Pharmacy, Drake University
    Director, Drake Drug Information Center

Sepsis in the leading cause of infectious disease mortality in the U.S.  The incidence and mortality of sepsis increases as patients age resulting in long term care residents being at particular risk of developing this condition.  Early recognition and treatment of sepsis can significantly improve outcomes.  This session will review the new screening criteria for sepsis, the 2017 Surviving Sepsis Guidelines and suggest simple, but effective, interventions for screening and the treatment in the long term care setting.

  • Describe the qSOFA screening system for sepsis and apply it to long term care patients
  • Discuss and implement the new Surviving Sepsis Guidelines
  • Assess strategies for fluid resuscitation in early sepsis
  • Select appropriate antimicrobials for long term care patients with early sepsis

1:45 pm


Workshop titles, presenters and times are subject to change. If necessary a substitute instructor will conduct the workshop. Program cancellations or changes in start time or location made by IHCA will be communicated to registrants via e-mail. IHCA reserves the right to cancel any education program, in which case, all fees will be refunded. If you require any special aides or services identified by the ADA, please contact IHCA prior to the program.


The following speakers and planning committee members have no conflicts with commercial interests to disclosure.

  • Cindy Baddeloo, PhD, Planning Committee Member and Speaker
  • Allen Bell, RPh, CGP, FASCP, Speaker
  • Katy Brown, PharmD, Speaker
  • Ryan Carnahan, RPhD, Planning Committee Member
  • Mary Jane Carothers, RN, Activity Director, Planning Committee Member
  • David R. Gifford, MD, MPH, Speaker
  • Christopher Hill, DO, Speaker
  • Jeff Reist, PharmD, Speaker
  • Dave Tomlin, Activity Director and Planning Committee Member
  • Geoffrey C. Wall, PhD, Speaker

The following speakers and planning committee members have a conflict(s) with commercial interests to disclosure.

  • Paul Mulhausen, MD, Planning Committee Member and Speaker - Employee of Telligen
  • Samuel E. Stanton, MD, Speaker - Consultant for The Community Doctor, LLC

The speakers will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration. Determination of educational content for this program and the selection of speakers are responsibilities of the activity director. Firms providing financial support did not have input in these areas.

Cancellation and Refunds

If a registrant cannot attend, an alternate registrant may attend in his/her place. Refunds will be granted only to those who cancel in writing to the IHCA∙ICAL office by 4 p.m. three business days prior to the program date. Cancellations after this time/date, no-shows due to weather, acts of God or illness, will be charged the full registration fee. This cancellation and refund policy does not apply to online courses. Refer to the course online brochure on the IHCA ICAL website for the specific cancellation and refund policy. 

Course summary
Available credit: 
  • 7.50 AMA PRA Category 1 Credits
  • 7.50 AOA Category 2­A
  • 7.50 CE Contact Hour(s)
Course opens: 
Course expires: 
Event starts: 
07/21/2017 - 1:00pm CDT
Event ends: 
07/22/2017 - 1:45pm CDT
Iowa Health Care Association
1775 90th Street
West Des Moines, IA 50266
United States
+1 (515) 978-2204


IHCA has secured a room block at the West Des Moines Marriott Hotel on the night of July 21, 2017 with special discounted sleeping room rates for the conference.

Marriott Hotel
1250 Jordan Creek Parkway
West Des Moines, IA

IHCA Room Rate:  $129 Single /Double + tax

To receive the special rate, you must request the “Iowa Health Care Association rate” when you make your reservation.

RATE CUT-OFF DATE: June 29, 2017

Continuing Education Credit

  • MD:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Health Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 7.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Other: This live activity is designated for a maximum of 7.5 AMA PRA Category 1 Credit(s)™.

Educational Grants

No commercial interest provided financial support for this continuing education activity.

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 7.50 AMA PRA Category 1 Credits
  • 7.50 AOA Category 2­A
  • 7.50 CE Contact Hour(s)


Please login or Create an Account to take this course.